ResearcherÜmraniye Eğitim ve Araştırma HastanesiActive in the last 2 years

Fikret Ezbercı

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3540-3822; OpenAlex author ID A5055275656. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer? Last author DOI 10.25259/cytojournal_2_2025 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tevhide Bilgen Özcan · 1 shared paper, 2025 · strength 0.27
- Paper Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes o… DOI 10.25259/cytojournal_2_2025 ↗
Ceren Canbey Göret · 1 shared paper, 2025 · strength 0.27
- Paper Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes o… DOI 10.25259/cytojournal_2_2025 ↗
Sena Şen · 1 shared paper, 2025 · strength 0.27
- Paper Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes o… DOI 10.25259/cytojournal_2_2025 ↗
Senem Karabulut · 1 shared paper, 2025 · strength 0.27
- Paper Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes o… DOI 10.25259/cytojournal_2_2025 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.